Patents by Inventor Mathilde Feist

Mathilde Feist has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oncolytic virus therapy
    Patent number: 12642832
    Abstract: The presently disclosed subject matter relates to tumor infiltrated T cells induced by oncolytic virus (“OV-induced T cells”), methods of making and using said OV-induced T cells for an adoptive T-cell therapy. The presently disclosed subject matter further relates to oncolytic viruses and armed oncolytic viruses, methods of making and using said oncolytic viruses, as well as pharmaceutical compositions and kits comprising said oncolytic viruses.
    Type: Grant
    Filed: June 11, 2025
    Date of Patent: June 2, 2026
    Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: ZongSheng Guo, David Bartlett, Zuqiang Liu, Mathilde Feist
  • ONCOLYTIC VIRUS THERAPY
    Publication number: 20250332208
    Abstract: The presently disclosed subject matter relates to tumor infiltrated T cells induced by oncolytic virus (“OV-induced T cells”), methods of making and using said OV-induced T cells for an adoptive T-cell therapy. The presently disclosed subject matter further relates to oncolytic viruses and armed oncolytic viruses, methods of making and using said oncolytic viruses, as well as pharmaceutical compositions and kits comprising said oncolytic viruses.
    Type: Application
    Filed: June 11, 2025
    Publication date: October 30, 2025
    Inventors: ZongSheng Guo, David Bartlett, Zuqiang Liu, Mathilde Feist
  • Oncolytic virus therapy
    Patent number: 12350303
    Abstract: The presently disclosed subject matter relates to tumor infiltrated T cells induced by oncolytic virus (“OV-induced T cells”), methods of making and using said OV-induced T cells for an adoptive T-cell therapy. The presently disclosed subject matter further relates to oncolytic viruses and armed oncolytic viruses, methods of making and using said oncolytic viruses, as well as pharmaceutical compositions and kits comprising said oncolytic viruses.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: July 8, 2025
    Assignee: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: Zong Sheng Guo, David Bartlett, Zuqiang Liu, Mathilde Feist
  • ONCOLYTIC VIRUS THERAPY
    Publication number: 20200000862
    Abstract: The presently disclosed subject matter relates to tumor infiltrated T cells induced by oncolytic virus (“OV-induced T cells”), methods of making and using said OV-induced T cells for an adoptive T-cell therapy. The presently disclosed subject matter further relates to oncolytic viruses and armed oncolytic viruses, methods of making and using said oncolytic viruses, as well as pharmaceutical compositions and kits comprising said oncolytic viruses.
    Type: Application
    Filed: February 5, 2018
    Publication date: January 2, 2020
    Inventors: Zong Sheng Guo, David Bartlett, Zuqiang Liu, Mathilde Feist